# Stryker and CMR Surgical form strategic alliance for Versius robot

Stryker will make a $400 million preferred equity investment in CMR Surgical, with an exclusive option to acquire the company, and will serve as exclusive U.S. sales agent for the Versius surgical robot portfolio.

- Type: Partnership
- Announced: 2026-10-12
- Value: $400.0M
- Status: announced
- Products: Versius surgical robot, soft-tissue robotics portfolio
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md), [Automation and Robotics](https://endata.com/sectors/automation-robotics.md)

## Companies

- [Stryker](https://endata.com/companies/15355.md) (investor)
- [CMR Surgical](https://endata.com/companies/15356.md) (partner)

## Sources

- [br.advfn.com](https://br.advfn.com/noticias/GLOBE/2026/artigo/99475480), 2026-10-12: "The alliance comes as demand for robotic-assisted surgery continues to grow, creating an opportunity to help healthcare providers expand robotic-assisted surgery programs with a scalable and practical solution."
- [cic.vc](https://www.cic.vc/cic-announces-portfolio-company-cmr-surgical-has-received-a-400-million-investment-and-formed-a-strategic-alliance-with-medtech-leader-stryker/), 2026-10-12: "Entering the US market is a critical commercial inflection point for CMR."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.